Training and Education for healthcare professionals, academia, and consumers from FDA’s Center for Drug Evaluation and Research
Similar Posts
Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity
Listen to FDA Drug Safety Podcast, FDA’s preliminary evaluation has not found evidence that use of GLP-1 RAs causes suicidal thoughts/actions.

Effective Blog Promotion: Strategies to Increase Your Reach
Introduction A key aspect of successful blogging is not just creating great content, but also effectively promoting it. This post will explore various strategies to increase the visibility and reach of your blog. 1. Leverage Social Media Platforms Utilize different social media platforms to promote your blog posts. Tailor your approach for each platform to…
Q&A with FDA Podcast
“Q&A with FDA” is a monthly podcast series that provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of the most commonly asked questions received by FDA. Perhaps you have had the same questions
East Orange VA Medical Center. East Orange, NJ. 483 issued 04/29/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 04/29/2025
Short Title (70 char) East Orange VA Medical Center. East Orange, NJ. 483 issued 04/29/2025
FEI Number 3011110195
Firm Name East Orange VA Medical Center
Record Type 483
State NJ
Establishment Type Pr
Record Date 04/29/2025
Short Title (70 char) East Orange VA Medical Center. East Orange, NJ. 483 issued 04/29/2025
FEI Number 3011110195
Firm Name East Orange VA Medical Center
Record Type 483
State NJ
Establishment Type Pr
2023 Meeting Materials, Cardiovascular and Renal Drugs Advisory Committee
This page contains the meeting materials for the Cardiovascular & Renal Drugs Advisory Committee meetings for 2023.
MHRA launches new digital hub in Leeds to drive innovation and regional growth
The new hub will strengthen the MHRA’s work with regional partners and boost the UK’s digital health and life sciences sector.